Netherlands vs Peru: HIV-positive TB patients on ART (antiretroviral therapy)
Netherlands
61.0%
in 2022
Peru
57.0%
in 2024
Netherlands rank
135th
Peru rank
137th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Netherlands
- Peru
How they compare
Netherlands currently reports 61.0% against 57.0% in Peru, a difference of 4.0%.
That makes Netherlands's figure about 1.1 times Peru's.
The two have swapped places 2 times across 9 shared years of data; in 2007 it was Netherlands ahead.
Netherlands ranks 135th and Peru ranks 137th of 144 countries.
Across the 3 decades both report, Netherlands averaged higher in 2 and Peru in 1.
Head to head by decade
| Decade | Netherlands | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 9.9% | 90.1% | Netherlands |
| 2010s | 63.2% | 64.2% | 1.0% | Peru |
| 2020s | 72.3% | 52.0% | 20.3% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Netherlands or Peru?
- Netherlands, at 61.0% against 57.0% in Peru as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Netherlands and Peru?
- 4.0%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Peru?
- 9 years are reported by both, from 2007 to 2022.
- How do Netherlands and Peru rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Netherlands ranks 135th and Peru ranks 137th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.